MassMutual Mid Cap Growth R5 holds a quantitatively derived Neutral Morningstar Medalist Rating. The rating suggests the model does not express a clear expectation of outperformance or underperformance relative to peers over a full market cycle.
MassMutual Mid Cap Growth Fund Class R5 MGRFX
- NAV / 1-Day Return 16.86 / +1.02 %
- Total Assets 2.5B
-
Adj. Expense Ratio
0.760%
- Expense Ratio 0.760%
- Distribution Fee Level Average
- Share Class Type Retirement, Large
- Category Mid-Cap Growth
- Investment Style Mid Growth
- Min. Initial Investment 0
- Status Open
- TTM Yield 0.00
- Turnover 38%
USD | NAV as of Jun 10, 2026 | 1-Day Return as of Jun 10, 2026, 12:26 AM GMT+0
Morningstar’s Analysis MGRFX
Will MGRFX outperform in the future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
The People Pillar is our evaluation of the MGRFX management team’s experience and ability. We find that high-quality management teams deliver superior performance relative to their benchmarks and/or peers.
Parent Pillar
The Parent Pillar is our rating of MGRFX’s parent organization’s priorities and whether they’re in line with investors’ interests.
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 17.3
|
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
|---|---|---|---|
Fixed Inc Clearing Corp.Repo | 2.28 | 63M | Cash and Equivalents |
Hilton Worldwide Holdings Inc | 2.01 | 55M | Consumer Cyclical |
XPO Inc | 1.97 | 54M | Industrials |
Monolithic Power Systems Inc | 1.90 | 53M | Technology |
Lattice Semiconductor Corp | 1.83 | 50M | Technology |
Agilent Technologies Inc | 1.80 | 50M | Healthcare |
Mettler-Toledo International Inc | 1.71 | 47M | Healthcare |
Burlington Stores Inc | 1.69 | 47M | Consumer Cyclical |
Cencora Inc | 1.50 | 41M | Healthcare |
Alnylam Pharmaceuticals Inc | 1.46 | 40M | Healthcare |
United States